<DOC>
	<DOC>NCT00960453</DOC>
	<brief_summary>The purpose of this study is to investigate the pharmacokinetics and pharmacodynamics of sitagliptin in healthy volunteers.</brief_summary>
	<brief_title>Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of Sitagliptin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Healthy male subjects aged 20 50 years A body mass index (BMI) in the range 1728 kg/m2 Fasting plasma glucose levels in the range 70110 mg/dL Sufficient ability to understand the nature of the study and any hazards of participating in it Provide written informed consent after being fully informed about the study procedures Presence or history of severe adverse reaction to any drug (e.g., sitagliptin) or a history of severe allergic disease Clinically relevant abnormal medical history that could interfere with the objectives of the study A subject who has the following screening laboratory test results; creatinine clearance (calculated by CockcroftGault equation) &lt; 80 mL/min History of gastrointestinal disease or surgery (except simple appendectomy or repair of hernia), which can influence the absorption of the study drug A subject whose SBP is over 150 mmHg or below 100 mmHg and DBP is over 95 mmHg or below 65 mmHg Presence or history of drug abuse Participation in other clinical trial within 2 months Use of a prescription medicine, herbal medicine within 2 weeks or overthecounter medication within 1 week before first dose Blood donation during 2 months or apheresis during 1 month before the study Presence or history of alcohol abuse Users of nicotinecontaining substances within the previous three months Use of grapefruit juice, alcohol or smoking during restriction period Subject judged not eligible for study participation by investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>